Modifications of the antioxidant enzymes in relation to chromosome imbalances in human melanoma cell lines

Melanoma Research

Volumn 8, Issue 4, 1998, Pages 329-335

  Bravard, A ^a   Cherbonnel Lasserre, C ^a   Reillaudou, M ^a   Beaumatin, J ^a   Dutrillaux, B ^a   Luccioni, C ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

Antioxidant metabolism; Cytogenetic; Melanoma; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; SUPEROXIDE DISMUTASE; THYMIDINE KINASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CHROMOSOME 6; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MODIFICATION; GENE DOSAGE; HUMAN; HUMAN CELL; MELANOMA CELL; METABOLIC REGULATION; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

CATALASE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; ISOENZYMES; MELANOCYTES; MELANOMA; NEOPLASM PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SEQUENCE DELETION; SKIN NEOPLASMS; SUPEROXIDE DISMUTASE; THYMIDINE KINASE; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

EID: 0031693157     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199808000-00006     Document Type: Article

References (45)

1. Borek C, Troll W. Modifiers of free radicals inhibit in vitro the oncogenic action of X-rays, bleomycin, and the tumor promoter 12-O-tetradecanoylphorhol 13-acetate. Proc Natl Acad Sci USA 1983; 80: 1304-1307.
2. Cerutti PA. Prooxidant state and tumor promotion. Science 1985; 227: 375-381.
3. Oberley LW. Superoxide dismutase and cancer. In: Oberley LW, ed. Superoxide Dismutase, Vol. 2. Boca Raton: CDC Press, 1983: 127-165.
4. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Rad Biol Med 1990; 8: 583-599.
5. Borrello S, De Leo ME, Galeotti T. Defective gene expression of MnSOD in cancer cells. Mol Aspects Med 1993; 14: 253-258.
6. Church SL, Grant JW, Meese EU, Trent JM. Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by in situ hybridization and somatic cell hybrid mapping. Genomics 1992; 14: 823-825.
7. Dutrillaux B, Gerbault-Seureau M, Zafrani B. Characterization of chromosomal anomalies in human breast cancer (a comparison of 30 paradiploid cases with few chromosome changes). Cancer Genet Cytogenet 1990; 49: 203-217.
8. Sandberg AA. The Chromosomes in Human Cancer and Leukemia, 2nd edn. New York: Elsevier, 1990.
9. Copeman MC. The putative melanoma tumor-suppressor gene on human chromosome 6q. Pathology 1992; 24: 307-309.
10. Hoffschir F, Ricoul M, Dutrillaux B. SV40-transformed human fibroblasts exhibited a characteristic chromosomal pattern. Cytogenet Cell Genet 1988; 49: 264-268.
11. Bravard A, Sabatier L, Hoffschir F, Ricoul M, Luccioni C, Dutrillaux B. SOD2: a new type of tumor-suppressor gene? Int J Cancer 1992; 51: 476-480.
12. Bravard A, Hoffschir F, Sabatier L, Ricoul M, Pinton A, Cassingena R, Estrade S, Luccioni C, Dutrillaux U. Early superoxide dismutase alterations during SV40-transformation of human fibroblasts. Int J Cancer 1992; 52: 797-801.
13. Safford SE, Oberley TD, Urano M, StClair DK. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase. Cancer Res 1994; 54: 4261-4265.
14. Li JJ, Oberley LW, StClair DK, Ridnour LA, Oberley TD. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 1995; 10: 1989-2000.
15. Zhong W, Oberley LW, Oberley TD, Yan T, Domann FE, StClair DK. Inhibition of cell growth and sensitization to oxidative damage by overexpression of manganese superoxide dismutase in rat glioma cells. Cell Growth Differ 1996; 7: 1175-1186.
16. Zhong W, Oberley LW, Oberley TD, StClair DK. Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 1997; 14: 481-490.
17. Pathak S, Drwinga HL, Hsu TC. Involvement of chromosome 6 in rearrangements in human malignant melanoma cell lines. Cytogenet Cell Genet 1983; 36: 573-579.
18. Singh AD, Boghosian-Sell L, Wary KK, Shields CL, De Potter P, Donoso LA, Shields JA, Cannizzaro LA. Cytogenetic findings in primary uveal melanoma. Cancer Genet Cytogenet 1994; 72: 109-115.
19. Speicher MR, Prescher G, Du Manoir S, Jauch A, Horsthemke B, Bornfeld N, Becher R, Cremer T. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res 1994; 54: 3817-3823.
20. Thompson FH, Emerson J, Olson S, Weinstein R, Leavitt SA, Leong SPL, Emerson S, Trent JM, Nelson MA, Salmon SE, Taetle R. Cytogenetics in 158 patients with regional or disseminated melanoma: subset analysis of near diploid and simple karyotypes. Cancer Genet Cytogenet 1995; 83: 93-104.
21. Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowski CM, Nagle RB. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 1990; 247: 568-571.
22. Welch DR, Chen P, Miele ME, McGary CT, Bower JM, Stanbridge EJ, Weissman BE. Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 1994; 9: 255-262.
23. Robertson GP, Coleman AB, Lugo TG. Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6. Cancer Res 1996; 56: 1635-1641.
24. Millikin D, Meese E, Volgelstein B, Witkowski C, Trent J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 1991; 51: 5449-5453.
25. Walker GJ, Palmer JM, Walters MK, Nancarrow DJ, Parsons PG, Hayward NK. Simple tandem repeat allelic deletions confirm the preferential loss of distal chromosome 6q in melanoma. Int J Cancer 1994; 58: 203-206.
26. Church SL, Grant JW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS, Trent JM. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci USA 1993; 90: 3113-3117.
27. Aubert C, Rouge F, Galindo JR. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro. J Natl Cancer Inst 1980; 64: 1029-1040.
28. Aubert C, Rouge F, Galindo JR. Differentiation and tumorigenicity of human malignant melanocytes in relation to their culture conditions. J Natl Cancer Inst 1984; 72: 3-12.
29. Aubert C, Rouge F, Reillaudou M, Medge P. Establishment and characterization of human ocular melanoma cell lines. Int J Cancer 1993; 54: 1-9.
30. Dutrillaux B, Couturier J. La Pratique de l'Analyse Chromosomique. Paris: Masson, 1981.
31. Human gene mapping 11. Cytogenet Cell Genet 1991; 58: 1-4.
32. Bravard A, Beaumatin J, Luccioni C, Fritsch P, Lefrancois D, Thenet S, Adolphe M, Dutrillaux B. Chromosomal, mitochondrial and metabolic alterations in SV40-transformed rabbit chondrocytes. Carcinogenesis 1992; 13: 767-772.
33. Bravard A, Beaumatin J, Dussaulx E, Lesuffleur T, Zweibaum A, Luccioni C. Modifications of the antioxidant metabolism during proliferation and differentiation of colon tumor cell lines. Int J Cancer 1994; 59: 843-847.
34. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162: 156-159.
35. Ho YS, Crapo JD. Isolation and characterization of complementary DNAs encoding human manganese-containing superoxide dismutase. FEBS Lett 1988; 229: 256-260.
36. Bravard A, Hoffschir F, Ricoul M, Cassingena R, Estrade S, Luccioni C, Dutrillaux B. Alterations of the glutathione cycle enzymes during and after SV40-transformation of human fibroblasts. Carcinogenesis 1993; 14: 21-24.
37. Kelner MJ, Bagnell R. Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase, and glutathione transferase activity in cells transfected with a copper-zinc superoxide expression vector. J Biol Chem 1990; 265: 10872-10875.
38. Goldstein BD, Roxen MG, Quintavalla JC, Amoruso MA. Decrease in mouse lung and liver glutathione peroxidase activity and potentiation of the lethal effects of ozone and paraquat by the superoxide dismutase inhibitor diethyldithiocarbamate. Biochem Pharmacol 1979; 28: 27-30.
39. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985; 240: 500-508.
40. Jensen PKA, Junien C, Despoisse S, Bersen A, Thelle T, Friedrich U, De La Chapelle A. Inverted tandem duplication of the short arm of chromosome 8: a non-random de novo structural aberration in man. Localization of the gene for glutathione reductase in subband 8p21.1. Ann Genet 1982; 25: 207-211.
41. Nevin NC, Morrisson PJ, Jones J, Macreid M. Inverted tandem duplication of 8p12>p23.1 in a child with increased activity of glutathione reductase. J Med Genet 1990; 27: 135-136.
42. Hoffschir F, Vuillaume M, Sabatier L, Ricoul M, DayaGrosjean L, Estrade S, Cassingena R, Calvayrac R, Sarasin A, Dutrillaux B. Decrease in catalase activity and loss of the 11p arm in the course of SV40 transformation of human fibroblasts. Carcinogenesis 1993; 14: 1569-1579.
43. Sinet PM, Lavelle F, Michelson AM, Jerome H. Superoxide dismutase activities of blood platelets in trisomy 21. Biochem Biophys Res Commun 1975; 67: 904-909.
44. Sinet PM. Metabolism of oxygen derivatives in Down's syndrome. Ann NY Acad Sci 1982; 396: 83-94.
45. Miele ME, McGary CT, Welch DR. SOD2 (MnSOD) does not suppress tumorigenicity or metastasis of human melanoma C8161 cells. Anticancer Res 1995; 15: 2065-2070.